GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Selling and Marketing Expense

Kadimastem (XTAE:KDST) Selling and Marketing Expense : ₪0.09 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Kadimastem's Selling and Marketing Expense for the six months ended in Dec. 2023 was ₪-0.18 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.09 Mil.

Kadimastem Selling and Marketing Expense Historical Data

The historical data trend for Kadimastem's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadimastem Selling and Marketing Expense Chart

Kadimastem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.21 0.45 0.30 0.09

Kadimastem Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.47 -0.17 0.27 -0.18

Kadimastem Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kadimastem Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Kadimastem's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kadimastem (XTAE:KDST) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Selling and Marketing Expense
Comparable Companies
XTAE:XTLB XTAE:BOLT XTAE:PLNT XTAE:CANF XTAE:HDST-M XTAE:MTLF XTAE:CBI XTAE:DNA XTAE:EVGN OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE
Traded in Other Exchanges
KMSTF:USA
Address
Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR
Website
http://www.kadimastem.com
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem (XTAE:KDST) Headlines

No Headlines